Skip to main content

and
  1. No Access

    Article

    Molecular mechanisms of non-genetic aberrant peptide production in cancer

    The cancer peptidome has long been known to be altered by genetic mutations. However, more recently, non-genetic polypeptide mutations have also been related to cancer cells. These non-genetic mutations occur ...

    Demi Wernaart, Amos Fumagalli, Reuven Agami in Oncogene (2024)

  2. Article

    Open Access

    Suppression of heparan sulfation re-sensitizes YAP1-driven melanoma to MAPK pathway inhibitors

    Accumulating evidence identifies non-genetic mechanisms substantially contributing to drug resistance in cancer patients. Preclinical and clinical data implicate the transcriptional co-activators YAP1 and its ...

    Sebastian M. Dieter, Domenica Lovecchio, Abhijeet Pataskar, Martina K. Zowada in Oncogene (2022)

  3. Article

    Open Access

    A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis

    Frequent activation of the co-transcriptional factor YAP is observed in a large number of solid tumors. Activated YAP associates with enhancer loci via TEAD4-DNA-binding protein and stimulates cancer aggressiv...

    Li Li, Alejandro P. Ugalde, Colinda L. G. J. Scheele, Sebastian M. Dieter in Genome Biology (2021)

  4. Article

    Open Access

    Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence

    Functional characterization of non-coding elements in the human genome is a major genomic challenge and the maturation of genome-editing technologies is revolutionizing our ability to achieve this task. Oncoge...

    Ruiqi Han, Li Li, Alejandro Piñeiro Ugalde, Arieh Tal, Zohar Manber in Genome Biology (2018)

  5. No Access

    Article

    Alternative cleavage and polyadenylation: extent, regulation and function

  6. Recent advances in technologies for global map** of alternative polyadenylation (APA) have allowed unprecedented investigation of alternative polyadenylation...

  7. Ran Elkon, Alejandro P. Ugalde, Reuven Agami in Nature Reviews Genetics (2013)

  8. Article

    Open Access

    p53 induces transcriptional and translational programs to suppress cell proliferation and growth

    Cell growth and proliferation are tightly connected to ensure that appropriately sized daughter cells are generated following mitosis. Energy stress blocks cell growth and proliferation, a critical response fo...

    Fabricio Loayza-Puch, Jarno Drost, Koos Rooijers, Rui Lopes, Ran Elkon in Genome Biology (2013)

  9. Article

    Open Access

    E2F mediates enhanced alternative polyadenylation in proliferation

    The majority of mammalian genes contain multiple poly(A) sites in their 3' UTRs. Alternative cleavage and polyadenylation are emerging as an important layer of gene regulation as they generate transcript isofo...

    Ran Elkon, Jarno Drost, Gijs van Haaften, Mathias Jenal, Mariette Schrier in Genome Biology (2012)

  10. No Access

    Article

    HBV integrants of hepatocellular carcinoma cell lines contain an active enhancer

    Hepatitis B virus (HBV) infection is a major risk factor worldwide for the development of hepatocellular carcinoma (HCC). Integrated HBV DNA fragments, often highly rearranged, are frequently detected in HCC. ...

    Meir Shamay, Reuven Agami, Yosef Shaul in Oncogene (2001)

  11. No Access

    Article

    The kinase activity of c-Abl but not v-Abl is potentiated by direct interaction with RFXI, a protein that binds the enhancers of several viruses and cell-cycle regulated genes

    c-Abl, the non-receptor tyrosine kinase is associated with EP, a DNA element found in promoters/enhancers of different viruses and cell-cycle regulated genes. EP-DNA binds RFXI, a member of a novel family of D...

    Reuven Agami, Yosef Shaul in Oncogene (1998)